MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
Abroad (travel likely)Recruiting
Conditions
Liver Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The University of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Michael Charlton, MD)